Revenue: The sum of all revenue fields included for a company's operating activities.
Fulgent Genetics, Inc. (FLGT) had Revenue of $81.80M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$81.80M |
$-18.96M |
|
$47.37M |
|
$34.44M |
|
$101.52M |
|
$-19.71M |
|
$-1.81M |
|
$-21.52M |
|
$-11.59M |
|
$-19.26M |
|
$-19.26M |
|
$-19.26M |
|
$-8.29M |
|
$-19.71M |
|
$-15.06M |
|
30.54M |
|
30.54M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$428.73M |
|
$110.22M |
|
$771.11M |
|
$1.20B |
|
$71.33M |
|
-- |
|
$16.87M |
|
$88.20M |
|
$1.11B |
|
$958.52M |
|
$1.11B |
|
30.61M |
|
| Cash Flow Statement Financials | |
$-34.60M |
|
$81.13M |
|
$-13.81M |
|
$55.28M |
|
$88.02M |
|
$32.74M |
|
$20.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.01 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
42.09% |
|
-24.10% |
|
-24.10% |
|
-- |
|
-26.31% |
|
-23.17% |
|
$-46.14M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.06 |
|
84.92 |
|
-1.73% |
|
-2.01% |
|
-1.60% |
|
-1.73% |
|
$36.32 |
|
$-1.51 |
|
$-1.13 |
|